William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Biohaven Announces Pricing of $225 Million Public Offering of Common Shares
-
William Blair Reiterates Outperform Rating on Biohaven Pharmaceutical (BHVN), Sees Nurtec ODT as Leader in Migraine Therapies
-
William Blair Reiterates Biohaven Pharmaceutical (BHVN) at Outperform, Nurtec ODT Will Eventually Become Blockbuster Franchise
-
Biohaven (BHVN) Defended at William Blair
-
Biohaven Pharmaceutical Holding (BHVN) Set Up For A Christmas Rally - William Blair
-
Biohaven Pharmaceutical Holding (BHVN) Reiterated Outperform at William Blair Despite CRL
-
Biohaven (BHVN) Prices 6.977M Shares Common Offering at $43/Sh
-
Biohaven Announces Pricing Of $300 Million Public Offering Of Common Shares
-
Biohaven Announces Closing Of $144M Public Offering Of Common Shares, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Biohaven (BHVN) Prices 3.355M Share Offering at $37.25/Sh
-
Biohaven Announces Pricing of Public Offering of Common Shares
-
Buy Biohaven Pharmaceutical (BHVN) On Weakness - William Blair
-
William Blair Starts Biohaven Pharmaceutical Holding (BHVN) at Outperform
-
Biohaven Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Biohaven Pharmaceutical (BHVN) IPO Opens up 18%
-
Biohaven Announces Pricing of Initial Public Offering of Common Shares
-
Biohaven Announces Pricing of Initial Public Offering of Common Shares

